Owner Glaxo Group Limited

Inventors Plumpton, Christopher; West, Michael Robert; Germaschewski, Volker; EonDuval, Alexandre; Ellis, Jonathan Henry; Rapson, Nicholas Timothy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005229457

PCT Pub. Number WO2005/095457

Priority 0407193.2 30.03.04 GB; 0407197.3 30.03.04 GB

Filing date 29 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 25 November 2010

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay